Building a global consensus approach to chordoma: a position paper from the medical and patient community (Q33275526)

25 July 2017

title

Building a global consensus approach to chordoma: a position paper from the medical and patient community (English)

1 reference

25 July 2017

0 references

1 reference

1

0 references

author name string

Josh Sommer

series ordinal

2

1 reference

25 July 2017

Chordoma Global Consensus Group

series ordinal

3

1 reference

25 July 2017

language of work or name

1 reference

1 February 2015

1 reference

Lancet Oncology Commission

25 July 2017

published in

1 reference

25 July 2017

volume

16

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

e71-83

1 reference

Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Descriptive epidemiology of sarcomas in Europe: report from the RARECARE project.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Soft tissue chordomas: a clinicopathologic analysis of 11 cases

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

T (brachyury) gene duplication confers major susceptibility to familial chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Brachyury, a crucial regulator of notochordal development, is a novel biomarker for chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Brachyury, SOX-9, and podoplanin, new markers in the skull base chordoma vs chondrosarcoma differential: a tissue microarray-based comparative analysis

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Sacrococcygeal chordoma: MR imaging in 30 patients.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Value of MRI in the diagnosis of non-clival, non-sacral chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Diagnostic imaging of solitary tumors of the spine: what to do and say.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas?

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Differentiating Benign Notochordal Cell Tumors From Chordomas: Radiographic Features on MRI, CT, and Tomography

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Differentiation of primary chordoma, giant cell tumor and schwannoma of the sacrum by CT and MRI.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Clival chordomas: clinical management, results, and complications in 71 patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Prognostic factors for long-term outcome of patients with surgical resection of skull base chordomas—106 cases review in one institution

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Outcome of 132 operations in 97 patients with chordomas of the craniocervical junction and upper cervical spine

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Primary chordomas of the cervical spine: a consecutive series of 14 surgically managed cases

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordomas of the skull base and cervical spine: clinical outcomes associated with a multimodal surgical resection combined with proton-beam radiation in 40 patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Current surgical outcomes for cranial base chordomas: cohort study of 95 patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Clinical characteristics, immunohistochemistry, and outcomes of 77 patients with skull base chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Male sex as a risk factor for the clinical course of skull base chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Sacral chordoma: 40-year experience at a major cancer center

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Prognostic factors in chordoma of the sacrum and mobile spine: a study of 39 patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Operative management of sacral chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Sacral chordomas: Impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordoma of the mobile spine: fifty years of experience

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordoma of the mobile spine and sacrum: a retrospective analysis of a series of patients surgically treated at two referral centers

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Posterior-only approach for en bloc sacrectomy: clinical outcomes in 36 consecutive patients

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

A uniform residual tumor (R) classification: integration of the R classification and the circumferential margin status.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

1 reference

7 January 2021

The biological basis for modern treatment of chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Endoscopic endonasal approach in the management of skull base chordomas--clinical experience on a large series, technique, outcome, and pitfalls

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Current comprehensive management of cranial base chordomas: 10-year meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Photon-based fractionated stereotactic radiotherapy for postoperative treatment of skull base chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Proton therapy for tumors of the skull base

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Effectiveness and safety of spot scanning proton radiation therapy for chordomas and chondrosarcomas of the skull base: first long-term report

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Radiation therapy for chordomas of the base of skull and cervical spine: patterns of failure and outcome after relapse

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Surgical seeding of chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Conventional external radiotherapy in the management of clivus chordomas with overt residual disease.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordomas of the base of the skull and upper cervical spine. One hundred patients irradiated by a 3D conformal technique combining photon and proton beams

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordoma: long-term follow-up after radical photon irradiation

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Carbon ion radiotherapy for skull base chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Stereotactic radiosurgery for chordoma: a report from the North American Gamma Knife Consortium

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Decision making in primary sacral tumors

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Long-term results: adjuvant radiotherapy in en bloc resection of sacrococcygeal chordoma is advisable.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Carbon ion radiotherapy for sacral chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordoma of the spinal column

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Analysis of the relationship between tumor dose inhomogeneity and local control in patients with skull base chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Level-adjusted perioperative risk of sacral amputations

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Spot-Scanning-Based Proton Therapy for Extracranial Chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Chordoma: current concepts, management, and future directions

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Diagnosis and treatment of chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Intraoperative dural irradiation by customized 192iridium and 90yttrium brachytherapy plaques

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Intraoperative 32P high-dose rate brachytherapy of the dura for recurrent primary and metastatic intracranial and spinal tumors.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Multidisciplinary management of recurrent chordomas

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Preliminary results of high-dose single-fraction radiotherapy for the management of chordomas of the spine and sacrum

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Cryoablation of recurrent sacrococcygeal tumors

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Phase II study of imatinib in advanced chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Response to imatinib plus sirolimus in advanced chordoma.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Response to erlotinib in a patient with treatment refractory chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Regression of cervical spinal cord compression in a patient with chordoma following treatment with cetuximab and gefitinib

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Phase II study on lapatinib in advanced EGFR-positive chordoma

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

1 reference

https://api.crossref.org/works/10.1016/S1470-2045(14)71190-8

7 January 2021

10.1016/S1470-2045(14)71190-8

Identifiers

DOI

1 reference

25 July 2017

1 reference